Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.
COVID-19
activation-induced marker assay
cellular immune response
mRNA vaccines
older adults
Journal
Pathogens & immunity
ISSN: 2469-2964
Titre abrégé: Pathog Immun
Pays: United States
ID NLM: 101683909
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
07
2023
accepted:
18
09
2023
medline:
30
11
2023
pubmed:
30
11
2023
entrez:
30
11
2023
Statut:
epublish
Résumé
While older adults generally mount weaker antibody responses to a primary COVID-19 vaccine series, T-cell responses remain less well characterized in this population. We compared SARS-CoV-2 spike-specific T-cell responses after 2- and 3-dose COVID-19 mRNA vaccination and subsequent breakthrough infection in older and younger adults. We quantified CD4+ and CD8+ T-cells reactive to overlapping peptides spanning the ancestral SARS-CoV-2 spike protein in 40 older adults (median age 79) and 50 younger health care workers (median age 39), all COVID-19 naive, using an activation-induced marker assay. T-cell responses were further assessed in 24 participants, including 8 older adults, who subsequently experienced their first SARS-CoV-2 breakthrough infection. A third COVID-19 mRNA vaccine dose significantly boosted spike-specific CD4+ and CD8+ T-cell frequencies to above 2-dose levels in older and younger adults. T-cell frequencies did not significantly differ between older and younger adults after either dose. Multivariable analyses adjusting for sociodemographic, health, and vaccine-related variables confirmed that older age was not associated with impaired cellular responses. Instead, the strongest predictors of CD4+ and CD8+ T-cell frequencies post-third-dose were their corresponding post-second-dose frequencies. Breakthrough infection significantly increased both CD4+ and CD8+ T-cell frequencies, to comparable levels in older and younger adults. Exploratory analyses revealed an association between HLA-A*02:03 and higher post-vaccination CD8+ T-cell frequencies, which may be attributable to numerous strong-binding HLA-A*02:03-specific CD8+ T-cell epitopes in the spike protein. Older adults mount robust T-cell responses to 2- and 3-dose COVID-19 mRNA vaccination, which are further boosted following breakthrough infection.
Identifiants
pubmed: 38035132
doi: 10.20411/pai.v8i1.613
pii: pai.v8i1.613
pmc: PMC10686373
doi:
Types de publication
Journal Article
Langues
eng
Pagination
117-135Informations de copyright
Copyright © 2023 Pathogens and Immunity.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest to declare.
Références
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
J Infect Dis. 2022 Apr 1;225(7):1129-1140
pubmed: 34888688
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Nat Aging. 2023 Jan;3(1):82-92
pubmed: 37118516
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
N Engl J Med. 2007 Oct 4;357(14):1373-81
pubmed: 17914038
Nat Aging. 2022 Oct;2(10):896-905
pubmed: 37118289
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Infect Dis. 2007 Jun 1;195(11):1694-704
pubmed: 17471440
Nature. 2021 Aug;596(7872):417-422
pubmed: 34192737
J Infect Dis. 2022 Sep 21;226(6):983-994
pubmed: 35543278
Nat Rev Immunol. 2019 Sep;19(9):573-583
pubmed: 31186548
Lancet. 2005 Oct 1;366(9492):1165-74
pubmed: 16198765
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072
pubmed: 33906236
Nat Immunol. 2022 Feb;23(2):186-193
pubmed: 35105982
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Nat Med. 2022 May;28(5):1050-1062
pubmed: 35177862
Immunity. 2021 Sep 14;54(9):2133-2142.e3
pubmed: 34453880
Hum Immunol. 2022 Dec;83(12):797-802
pubmed: 36229378
Clin Infect Dis. 2022 Nov 30;75(11):1980-1992
pubmed: 35438175
EClinicalMedicine. 2023 Apr;58:101926
pubmed: 37034357
Virus Res. 2021 Nov;305:198579
pubmed: 34560183
Immunogenetics. 2023 Jun;75(3):309-320
pubmed: 36534127
JAMA Netw Open. 2022 Jun 1;5(6):e2218505
pubmed: 35749115
HLA. 2023 Sep;102(3):301-315
pubmed: 37010080
Viruses. 2021 Apr 28;13(5):
pubmed: 33925055
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
N Engl J Med. 2022 Jan 27;386(4):340-350
pubmed: 35021002
Front Immunol. 2013 Jun 04;4:131
pubmed: 23761790
Open Forum Infect Dis. 2023 Feb 09;10(3):ofad073
pubmed: 36910697